F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a
licensed pharmacist.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
medical record review, staff interview, review of the hospice contract, and review of the facility policy, the
facility failed to ensure pain medications were available for a resident experiencing pain and discomfort at
the end of life. This affected one (Resident #32) of three residents reviewed for pain management. The
facility census was 28.
Findings include:
Review of the medical record for Resident #32 revealed an admission date of 01/10/18 and a discharge
date of 02/12/24. Diagnoses included Parkinson's disease, dementia, and chronic kidney disease (CKD).
Review of the significant change Minimum Data Set (MDS) assessment dated [DATE] revealed Resident
#32 was admitted to hospice services. Resident #32 was cognitively impaired.
Review of the physician orders for Resident #32 revealed an admission date to hospice care on 02/07/24,
and morphine sulfate 20 milligram (mg)/milliliter (ml) and give 0.5 ml every two hours for pain and/or
shortness of breath (SOB), written on 02/09/24 at 2:50 P.M.
Review of the nursing notes dated 02/08/24 untimed, revealed Resident #32 was medicated for pain with
Tylenol (treats mild pain), awaiting order at this time, and pain noted with turning/providing care.
The nursing note dated 02/09/24 untimed, revealed during morning care, Resident #32 was reluctant to
move and moaned and grimacing with each movement. Hospice notified and aware, will address each
issue and notify the power of attorney (POA).
The nursing note dated 02/10/24, untimed, revealed Resident #32 exhibited increased discomfort still
awaiting medications/physician order clarification on call notified.
The nursing note dated 02/10/24 at 12:16 A.M. revealed Resident #32's morphine medication did not arrive
with delivery from pharmacy, spoke with pharmacy and they informed me that the quantity needed clarified
and new e-script in order to fill. Hospice contacted and updated with the clarification needs and updated
that Resident #32 was in pain. Hospice followed up confirming they sent the clarification and e-script in. The
nurse then called pharmacy and requested an authorization from the pharmacist to pull medication from
the starter box, technician confirmed that they did receive it and sent request as urgent. After not hearing
back a second request was made, now stating they needed the
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 2
Event ID:
366031
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
366031
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
03/07/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Mill Manor Care Center
983 Exchange St
Vermilion, OH 44089
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
same clarification again. The nurse informed the technician that both of them and hospice confirmed again
expressed the need for medication and multiple attempts have been made since approximately 7:00 P.M.
and it was now 12:16 A.M.
The nursing note dated 02/11/24 at 12:50 A.M. revealed the pharmacist called and gave authorization to
pull medication, and medication administered and effective.
Review of Resident #32's Medication Administration Record (MAR) for February 2024 revealed the first
dose of morphine sulfate was administered on 02/11/24 at 12:55 A.M. and was effective.
Interview on 03/05/24 at 12:09 P.M. with Licensed Practical Nurse (LPN) #111 stated there was an issue
with getting pain medication for Resident #32 when she was ordered morphine. LPN #111 stated the
physician order needed clarification and it took some time to get it corrected and once it was corrected she
was working and pulled it immediately gave the resident something for pain.
Interview on 03/05/24 at 3:53 P.M. with Pharmacist #144 stated the original order was written on 02/09/24
at 1:56 P.M. for morphine sulfate 20 mg/ml to give 15 ml bottle. The pharmacy called the provider for
updated order to change quantity bottle from 15 ml to 30 ml due to facility inhouse stock. Pharmacist #144
stated clarification order was obtained on 02/10/24 at 7:53 P.M. and corrected the order per pharmacy
request. Pharmacist #144 stated the pharmacy cannot fill an opioid without the order being exactly correct.
Pharmacist #144 stated this would be considered to have been a delay of treatment if the resident was
experiencing pain per the medical records.
Review of the facility policy titled Pain Management, updated 04/2023, revealed the facility identifies each
resident at risk for pain and/or experiencing actual pain and adequately plans care and implements
procedures to reduce the risk for pain. If pain occurs, the nurse will assess for type and location including
pain scale rating and as needed (PRN) pain medication will be administered as ordered.
Review of the facility policy titled,Contingency/Starter Medication Supply dated 09/2017 revealed
accuscripts pharmacy will provide limited, customized supplied of medication that may be needed to initiate
therapy before the next scheduled delivery occurs. For controlled medications, a valid control prescription
must be present in order for a contingency/starter supply to be utilized. Schedule II prescriptions must be
written by a physician or certified nurse practitioner with a DEA license designated for C-II and faxed to the
pharmacy. A valid prescription consists of the following: valid date not older than six months for a schedule
III-V or 60 days for a schedule II, patient name, date of birth , and address, drug information with drug
name, strength, form, directions, quantity, and refills (refills are not valid on Schedule II prescriptions.),
physician information name, address, signature, phone number, DEA number.
Review of the hospice contract dated 01/2024, revealed hospice will obtain orders for pain medication and
medications needed to palliate symptoms from the primary care physician and/or the hospice medical
director.
This deficiency represents non-compliance investigated under Master Complaint Number OH00151079 and
Complaint Number OH00150991.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
366031
If continuation sheet
Page 2 of 2